ArticleInternational journal of biological sciences2022

Isovalerylspiramycin I suppresses non-small cell lung carcinoma growth through ROS-mediated inhibition of PI3K/AKT signaling pathway.

Zeyu Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.